Bayer in review, looking to consolidate agencies

Share this article:
Bayer HealthCare put its global account into review, and plans to make decisions and finalize negotiations by the end of the third quarter.

According to a report in Advertising Age, the account is worth at least $1 billion. The review will include roster shops that currently work on Bayer's brands, according to Ad Age.

Susan Yarin, directory of global communications at Bayer HealthCare, called the global review a “Creative Sourcing Initiative,” and said the project “will include a review of the company's processes, partners and overall approach in the areas of creative services and media buying.”

Yarin said that in addition to creative and media buying, the review would cover “medical education, digital and public relations…on all brands.” The entire process is expected to be completed during 2010, said Yarin.
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Channel

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Channel

Five things for pharma marketers to know: Monday, September 15

Five things for pharma marketers to know: ...

Pharma has sought 76 meetings with FDA over biosimilars; Gilead licenses Sovaldi to India generic drugmakers; Pfizer and Ranbaxy Lipitor lawsuit dismissed.

Liraglutide, aiming for new indication, gets new name

Liraglutide, aiming for new indication, gets new name

Why Novo Nordisk is choosing not to leverage Victoza's brand equity as it seeks a weight-loss indication for liraglutide.

Five things for pharma marketers to know: Friday, September 12

Five things for pharma marketers to know: Friday, ...

An FDA panel voted in favor of liraglutide for weight loss; Allergan investors backing an attempted takeover of the firm crossed a critical threshold; and 100 million health wearables are ...